Hongbo Dong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hongbo Dong has a total of 115 co-authors. Here are the top co-authors by number of shared publications:
Yujiao He
School of Pharmacy, Chengdu University, Chengdu 610106, China
12 shared publicationsMin Wu
Antibiotics Research and Re-evaluation Key Laboratory of Sichuan Province, School of pharmacy, Chengdu University, Chengdu, China
8 shared publicationsBin Long
7 shared publicationsTing Peng
7 shared publicationsLan Lu
Anti-infective Agent Creation Engineering Research Centre of Sichuan Province, School of Pharmacy, Chengdu University, Chengdu, 610106, China
6 shared publicationsMengqi Wang
School of Pharmacy, Chengdu University, Chengdu 610106, China
6 shared publications
Latest Publications
- 18 September 2026
- Published by Elsevier in Bioorganic Chemistry
- Vol. 182, 110556
Cationic amphiphilic scandenone derivatives as membrane-active anti-MRSA agents
- 18 September 2026
- Published by Elsevier in Bioorganic Chemistry
- Vol. 182, 110556
Cationic amphiphilic scandenone derivatives as membrane-active anti-MRSA agents
- 22 July 2026
- Published by Elsevier in Fitoterapia
- Vol. 193, 107410
Total synthesis and anti-inflammatory evaluation of two prenylated coumestans
- 22 July 2026
- Published by Elsevier in Fitoterapia
- Vol. 193, 107410
Total synthesis and anti-inflammatory evaluation of two prenylated coumestans
- 4 July 2026
- Published by Elsevier in Tetrahedron
- Vol. 199
Total synthesis of (±)-cimifugin and anti-inflammatory evaluation of its ester derivatives
- 4 July 2026
- Published by Elsevier in Tetrahedron
- Vol. 199
Total synthesis of (±)-cimifugin and anti-inflammatory evaluation of its ester derivatives
- 14 June 2026
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 316, 119057
Total synthesis, antibacterial activity, and mechanistic characterization of erycristagallin as a promising anti-MRSA lead
- 14 June 2026
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 316, 119057
Total synthesis, antibacterial activity, and mechanistic characterization of erycristagallin as a promising anti-MRSA lead
- 26 January 2026
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 89 (2) , 692-700
Total Syntheses and Anti-Inflammatory Evaluation of Pd-Ib and Its Natural Stereoisomers
We reported the first enantioselective total synthesis of four naturally occurring angular dihydropyranocoumarins (1-4), each obtained in high enantiomeric excess (94-98% ee). The synthetic route featured Jacobsen epoxidation followed by anhydride-mediated angeloylation as key transformations. The anti-inflammatory properties of compounds 1-4 were evaluated using a panel of in vitro assays. Notably, compound 4 exhibited significant anti-inflammatory activity by reducing the secretion of proinflammatory cytokines. Results from Western blotting, in conjunction with molecular dynamics analysis, indicated that inhibition of the NF-κB signaling pathway may partially explain the anti-inflammatory activity of compound 4.
- 26 January 2026
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 89 (2) , 692-700
Total Syntheses and Anti-Inflammatory Evaluation of Pd-Ib and Its Natural Stereoisomers
We reported the first enantioselective total synthesis of four naturally occurring angular dihydropyranocoumarins (1-4), each obtained in high enantiomeric excess (94-98% ee). The synthetic route featured Jacobsen epoxidation followed by anhydride-mediated angeloylation as key transformations. The anti-inflammatory properties of compounds 1-4 were evaluated using a panel of in vitro assays. Notably, compound 4 exhibited significant anti-inflammatory activity by reducing the secretion of proinflammatory cytokines. Results from Western blotting, in conjunction with molecular dynamics analysis, indicated that inhibition of the NF-κB signaling pathway may partially explain the anti-inflammatory activity of compound 4.
- 30 July 2025
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 88 (8) , 2000-2007
Total Synthesis and Antimicrobial Evaluation of Bisoflavolin D: A Novel Biflavonoid from Streptomyces sp.
Bisoflavolin D (1) is a structurally unique biflavonoid originally isolated from Streptomyces sp. strain HDN154127 and exhibits potent antibacterial activity. However, its extremely low natural abundance has limited further biological investigation. Herein, we report the first total synthesis of bisoflavolin D (1). The key steps of our synthesis include three Suzuki-Miyaura cross-coupling reactions to construct the isoflavone monomers and establish the C-3‴-C-8 linkage of the biflavonoid scaffold. Preliminary antimicrobial testing revealed moderate antibacterial activity against Gram-positive pathogens, with a notable synergistic effect observed between bisoflavolin D (1) and norfloxacin (FICI = 0.28) against methicillin-resistant Staphylococcus aureus, as well as with amikacin against Escherichia coli (FICI < 0.16). This work provides a foundation for further exploration of bisoflavolin D (1) and its potential as an antimicrobial agent.
- 30 July 2025
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 88 (8) , 2000-2007
Total Synthesis and Antimicrobial Evaluation of Bisoflavolin D: A Novel Biflavonoid from Streptomyces sp.
Bisoflavolin D (1) is a structurally unique biflavonoid originally isolated from Streptomyces sp. strain HDN154127 and exhibits potent antibacterial activity. However, its extremely low natural abundance has limited further biological investigation. Herein, we report the first total synthesis of bisoflavolin D (1). The key steps of our synthesis include three Suzuki-Miyaura cross-coupling reactions to construct the isoflavone monomers and establish the C-3‴-C-8 linkage of the biflavonoid scaffold. Preliminary antimicrobial testing revealed moderate antibacterial activity against Gram-positive pathogens, with a notable synergistic effect observed between bisoflavolin D (1) and norfloxacin (FICI = 0.28) against methicillin-resistant Staphylococcus aureus, as well as with amikacin against Escherichia coli (FICI < 0.16). This work provides a foundation for further exploration of bisoflavolin D (1) and its potential as an antimicrobial agent.
- 5 July 2025
- Published by Elsevier in Tetrahedron
- Vol. 185
Total synthesis and reconfirmation of the absolute configuration of melanochromone
- 5 July 2025
- Published by Elsevier in Tetrahedron
- Vol. 185
Total synthesis and reconfirmation of the absolute configuration of melanochromone
- Open Access
- 15 April 2025
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 10 (16) , 16265-16276
Total Synthesis of Auriculatin and Millexatin F and Discovery of Their Antibacterial Mechanism
The emergence of multidrug-resistant (MDR) bacteria necessitates the urgent development of novel antibacterial agents. This study reported the first total synthesis of two antibacterial isoflavones, auriculatin (1) and millexatin F (2), derived from the tropical medicinal plant Millettia extensa. Through in vitro evaluations, both compounds 1 and 2 possessed significant antibacterial activities (MICs = 0.5-4 μg/mL) and rapid bactericidal properties against Gram-positive bacteria, along with high safety for mammalian cells. Mechanistic studies revealed that auriculatin (1) and millexatin F (2) interact with bacterial cell membranes, inducing alterations in bacterial morphology and membrane permeability and inducing a rise in the leakage of intracellular DNA and proteins, thereby leading to bacterial death. In addition, our studies indicated that millexatin F (2) could interact with phosphatidylethanolamine (PE) and cardiolipin (CL) of cytoplasmic membranes in both Gram-positive and Gram-negative bacteria. Furthermore, millexatin F (2) showed increased efficacy against Gram-negative bacteria when combined with a permeabilizer (polymyxin B nonapeptide), indicating potential for broader application. These findings underscore the therapeutic promise of auriculatin (1) and millexatin F (2) as lead candidates in the fight against bacterial infections.
- 15 April 2025
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 10 (16) , 16265-16276
Open AccessTotal Synthesis of Auriculatin and Millexatin F and Discovery of Their Antibacterial Mechanism
The emergence of multidrug-resistant (MDR) bacteria necessitates the urgent development of novel antibacterial agents. This study reported the first total synthesis of two antibacterial isoflavones, auriculatin (1) and millexatin F (2), derived from the tropical medicinal plant Millettia extensa. Through in vitro evaluations, both compounds 1 and 2 possessed significant antibacterial activities (MICs = 0.5-4 μg/mL) and rapid bactericidal properties against Gram-positive bacteria, along with high safety for mammalian cells. Mechanistic studies revealed that auriculatin (1) and millexatin F (2) interact with bacterial cell membranes, inducing alterations in bacterial morphology and membrane permeability and inducing a rise in the leakage of intracellular DNA and proteins, thereby leading to bacterial death. In addition, our studies indicated that millexatin F (2) could interact with phosphatidylethanolamine (PE) and cardiolipin (CL) of cytoplasmic membranes in both Gram-positive and Gram-negative bacteria. Furthermore, millexatin F (2) showed increased efficacy against Gram-negative bacteria when combined with a permeabilizer (polymyxin B nonapeptide), indicating potential for broader application. These findings underscore the therapeutic promise of auriculatin (1) and millexatin F (2) as lead candidates in the fight against bacterial infections.
- 6 February 2025
- Published by Royal Society of Chemistry (RSC) in Green Chemistry
- Vol. 27 (11) , 2989-2994
Visible-light-induced oxytrifluoromethylthiolation of α-diazo esters
An efficient and green method has been developed to construct a series of highly functionalized trifluoromethylthiolated scaffolds via the visible-light-induced oxytrifluoromethylthiolation of α-diazo esters and PhtSCF3 derivatives.
- 6 February 2025
- Published by Royal Society of Chemistry (RSC) in Green Chemistry
- Vol. 27 (11) , 2989-2994
Visible-light-induced oxytrifluoromethylthiolation of α-diazo esters
An efficient and green method has been developed to construct a series of highly functionalized trifluoromethylthiolated scaffolds via the visible-light-induced oxytrifluoromethylthiolation of α-diazo esters and PhtSCF3 derivatives.